CDKL5

CDKL5 is an X-linked genetic disorder characterized by seizures that begin in infancy. It results in severe developmental delays.

CDKL5 deficiency disorder usually begins within the first 3 months of life, and can appear as early as the first week after birth. Seizures occur daily in most affected people.

Most children with CDKL5 have severe intellectual disability and little or no speech. There is no current targeted treatment or gene therapy for CDKL5 disorder, it is managed primarily through different forms of therapy.

The latest on our research

We are jumpstarting our CDKL5 program to accelerate research on the disorder and welcome all parents interested in participating and spreading the word to the CDKL5 community.